Glucose Elevating Agents Market to Register a Steady Revenue CAGR of 6.3% by 2031 | Growth Plus Reports

Newark, New Castle, USA, May 03, 2023 (GLOBE NEWSWIRE) — Growth Plus Reports estimated the global market for glucose elevating agents in 2022 and is expected to increase at a revenue CAGR of 6.3% during the forecast period 2023-2031.

The global market for glucose elevating agents was analyzed and is expected to rise with a significant revenue share during the forecast period. Agents that elevate blood glucose levels are known as glucose-raising agents. In patients with low blood sugar levels, these drugs treat hypoglycemia, insulinoma, and other diabetes-related disorders.

Key Takeaways: 

• The increasing adoption of glucose monitoring devices also drives the demand for glucose elevating agents.
• Rapid advancement in innovative healthcare devices is driving the market demand.
• The increasing prevalence of diabetes is increasing the market revenue share.

Get a Free Sample Research Report: https://www.growthplusreports.com/inquiry/request-sample/glucose-elevating-agents-market/8867

                          Glucose Elevating Agents Market Scope

Recent Development in the Global Glucose Elevating Agents Market: 

• In December 2022, beginning on December 1, 2022, Novo Nordisk Pharma will distribute “Glucagon G Novo 1 mg” instead of EA Pharma Co., Ltd.

Competitive Landscape

A list of prominent players operating in the global market for glucose elevating agents includes: 

• E5 Pharma Inc. 
• Novitium Pharma
• Eli Lilly and Company
• Par Pharmaceutical
• Teva Pharmaceuticals USA, Inc.

Market Drivers and Restraints: 

The global glucose elevating agents market revenue is driven by the prevalence of diabetes, the growing adoption of glucose monitoring devices, and the developing reliability of a cost-effective solution. Furthermore, the increasing focus on developing innovative and advanced devices monitoring glucose levels in seconds is likely to contribute potential growth the global market revenue.

However, the market revenue share is expected to be restrained due to the stringent regulatory environment. 

Market Segmentation: 

• Based on products, the global glucose elevating agents market is segmented into glucagon, diazoxide, vitamins and supplements, and others. 
• Based on the indication, the global glucose elevating agents market is segmented into hypoglycemia, diabetic ketoacidosis, adrenal insufficiency, insulinoma, and others. 
• Based on the route of administration, the global glucose elevating agents market is segmented into oral and parenteral.
• Based on the distribution channel, the global glucose elevating agents market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/glucose-elevating-agents-market/8867

Segmentation By Indication

Based on indication, the hypoglycemia segment with the largest revenue share dominates the global glucose elevating agents market. This significant revenue share is attributed to it being the most common complication of diabetes treatment. Furthermore, an increasing number of people are leading a sedentary lifestyle with the consumption of alcohol and lack of physical activity. 

Regional Growth Dynamics

Based on the region, the global glucose elevating agents market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. Due to a large number of patients population living suffering from diabetes, significant market players, and a high level of knowledge and awareness, North America, with the largest revenue share, dominates the global market.

Report Coverage 

Growth Plus Reports analyzed the global market for glucose elevating agents in-depth. We studied the fundamental market characteristics, significant investment sectors, regional growth analytics, revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecast Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL GLUCOSE ELEVATING AGENTS MARKET – ANALYSIS & FORECAST, BY PRODUCT
   1. Glucagon
   2. Diazoxide
   3. Vitamins and Supplements
   4. Others
6. GLOBAL GLUCOSE ELEVATING AGENTS MARKET – ANALYSIS & FORECAST, BY INDICATION
   1. Hypoglycemia
   2. Diabetic Ketoacidosis
   3. Adrenal Insufficiency
   4. Insulinoma
   5. Others
7. GLOBAL GLUCOSE ELEVATING AGENTS MARKET – ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
   1. Oral
   2. Parenteral

GLUCOSE ELEVATING AGENTS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8867

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Biological and Chemical Indicators Market by Type (Biological Indicators and Chemical Indicators), End User (Biopharma Industries, Academic & Research Institutes) – Global Outlook & Forecast 2023-2031

Gene Therapy in CNS Disorder Market by Indication (Alzheimer’s Disease, Huntington’s Disease, Parkinson’s Disease), Type (Ex Vivo, In Vivo), End User (Hospitals, Speciality Clinics) – Global Outlook & Forecast 2023-2031

Secondary Myelofibrosis Therapeutics Market by Drug Class (Janus Kinase Inhibitors, Immunomodulating Agents), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

Ergocalciferol Market by Application (Hypoparathyroidism, Rickets), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

MISME Syndrome Market by Treatment (Surgery, Radiotherapy, Pharmacotherapy) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.